BeOne Medicines Ltd. - Sponsored ADR (ONC) shares ended the last trading session 4% higher at $290.35. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.4% gain over the past four weeks.The recent stock price rally can be attributed to growing investor optimism regarding the sales growth potential of the company’s internally discovered oncology products, including Brukinsa (zanubrutinib) and Tevimbra (tislelizuma ...